METHODS FOR TREATING AUTOIMMUNE DISEASES USING A TACI-IG FUSION MOLECULE

摘要

The present invention provides methods and compositions for treatment of autoimmune diseases, including rheumatoid arthritis, for example comprising administering to a patient in need of such treatment a TACI-Ig fusion molecule, wherein said composition is administered in amount of about 0.01 mg per of patient's body weight to about 10 mg/kg body weight 7 times during a twelve-week interval; or 3 times during a four-week interval; or every other week for 2 to 30 weeks; or once in every week.